|
Freiburg, February 2007 ProQinase will identify novel biomarkers for anti-tumor therapies as member of the EU-research consortium "ANGIOTARGETIN - European Consortium for Tumor Angiogenesis Research" San Diego and Freiburg, November 7, 2005 ChemDiv, Inc. and ProQinase GmbH to Partner in Lead Discovery and Preclinical Development in Oncology Duesseldorf and Freiburg, July 18, 2005 ProQinase and University of Duesseldorf receive BMBF-Grant for German-Chinese Research Project for the discovery of novel drugs for the treatment of cancer and viral diseases Martinsried/Munich, Freiburg and Reutlingen, June 17, 2005 MorphoSys Antibodies by Design, ProQinase and Natural and Medical Sciences Institute (NMI) receive BMBF-promotion for Kinome-project Freiburg, October 2004 ProQinase participates in EU FP6 Research Program „Protein Kinases – Novel Drug Targets of Post Genomic Era“ Martinsried and Freiburg, Germany, April 28, 2003 4SC and ProQinase collaborate on the discovery of new protein kinase inhibitors for cancer treatment Freiburg, Germany, January 23, 2003 ProQinase receives "Freiburg Innovation Award 2002" for its Integrated Technology Platform Protein Kinases
|
|